IL135511A0 - 2-arylbenzo[b] thiophenes useful for the treatment of estrogen deprivation syndrome - Google Patents

2-arylbenzo[b] thiophenes useful for the treatment of estrogen deprivation syndrome

Info

Publication number
IL135511A0
IL135511A0 IL13551198A IL13551198A IL135511A0 IL 135511 A0 IL135511 A0 IL 135511A0 IL 13551198 A IL13551198 A IL 13551198A IL 13551198 A IL13551198 A IL 13551198A IL 135511 A0 IL135511 A0 IL 135511A0
Authority
IL
Israel
Prior art keywords
arylbenzo
treatment
estrogen deprivation
deprivation syndrome
thiophenes
Prior art date
Application number
IL13551198A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL135511A0 publication Critical patent/IL135511A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IL13551198A 1997-11-14 1998-11-09 2-arylbenzo[b] thiophenes useful for the treatment of estrogen deprivation syndrome IL135511A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6585497P 1997-11-14 1997-11-14
PCT/US1998/023719 WO1999025707A1 (en) 1997-11-14 1998-11-09 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME

Publications (1)

Publication Number Publication Date
IL135511A0 true IL135511A0 (en) 2001-05-20

Family

ID=22065580

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13551198A IL135511A0 (en) 1997-11-14 1998-11-09 2-arylbenzo[b] thiophenes useful for the treatment of estrogen deprivation syndrome

Country Status (20)

Country Link
US (2) US6096781A (xx)
EP (1) EP0920862A1 (xx)
JP (1) JP2001523676A (xx)
KR (1) KR20010031903A (xx)
CN (1) CN1109683C (xx)
AU (1) AU748395B2 (xx)
BR (1) BR9813996A (xx)
CA (1) CA2309859A1 (xx)
EA (1) EA003471B1 (xx)
HR (1) HRP20000288A2 (xx)
HU (1) HUP0004731A3 (xx)
ID (1) ID26865A (xx)
IL (1) IL135511A0 (xx)
NO (1) NO20002371L (xx)
NZ (1) NZ503988A (xx)
PL (1) PL340431A1 (xx)
TR (1) TR200001288T2 (xx)
TW (1) TW467909B (xx)
WO (1) WO1999025707A1 (xx)
ZA (1) ZA9810214B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39049E1 (en) 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US6096781A (en) 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
US6087378A (en) * 1998-10-13 2000-07-11 Eli Lilly And Company Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
DE19913349A1 (de) * 1999-03-24 2000-09-28 Clariant Gmbh Benzothiophene und ihre Verwendung in flüssigkristallinen Mischungen
US20050229267A1 (en) * 2002-02-20 2005-10-13 J.R. Simplot Company Precise breeding
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
US20060106010A1 (en) * 2003-05-27 2006-05-18 Black Larry J Methods for inhibiting bone loss
ITTO20040125A1 (it) * 2004-03-01 2004-06-01 Rotta Research Lab Nuove amidine eterocicliche inibitrici la produzione di ossido d'azoto (no) ad attivita' antinfiammatoria ed analgesica
WO2006071868A2 (en) * 2004-12-23 2006-07-06 Teva Pharmaceutical Industries Ltd. Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof
KR101123178B1 (ko) * 2009-04-09 2012-06-13 (주)에스메디 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물
CA2928131C (en) 2012-10-24 2023-02-07 The Board Of Trustees Of The University Of Illinois Benzothiophene derivatives and use thereof for treating estrogen-related medical disorders
EP2911660B1 (en) * 2012-10-24 2019-12-04 The Board of Trustees of the University of Illionis Compositions and methods for treating estrogen-related medical disorders
CN107325067B (zh) * 2017-05-03 2020-05-12 广州中医药大学 磷酸二酯酶4抑制剂桑辛素m衍生物及其用途

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4588484A (en) * 1985-02-28 1986-05-13 Eli Lilly And Company Electrochemical reduction of 3-chlorobenzo[b]thiophenes
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
TW383306B (en) * 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
US5391557A (en) * 1993-10-15 1995-02-21 Eli Lilly And Company Methods for the treatment of peri-menopausal syndrome
US5462950A (en) * 1993-12-21 1995-10-31 Eli Lilly And Company Methods of treating menstrual symptoms and compositions therefore
US5534526A (en) * 1993-12-21 1996-07-09 Eli Lilly And Company Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome
US5389670A (en) * 1993-12-21 1995-02-14 Eli Lilly Company Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease
US5591753A (en) * 1994-01-28 1997-01-07 Eli Lilly And Company Combination treatment for osteoporosis
US5811120A (en) * 1994-03-02 1998-09-22 Eli Lilly And Company Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
US5972383A (en) * 1994-03-02 1999-10-26 Eli Lilly And Company Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
IL132954A (en) * 1995-02-28 2002-02-10 Lilly Co Eli Derivatives of benzothiophene
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
US5514703A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophene compounds useful for inhibiting lipoxygenase
US5514704A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophenes to inhibit leukotrienes
US5532382A (en) * 1995-03-13 1996-07-02 Eli Lilly And Company Benzothiophenes substituted at the 3-carbonyl
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss
US6444688B1 (en) * 1995-06-07 2002-09-03 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side chains
WO1997001549A1 (en) * 1995-06-26 1997-01-16 Eli Lilly And Company Benzothiophene compounds
US5731342A (en) * 1996-02-22 1998-03-24 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.
ID24978A (id) * 1997-11-14 2000-08-31 Lilly Co Eli 2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN
US6096781A (en) * 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome

Also Published As

Publication number Publication date
US6395769B1 (en) 2002-05-28
CN1109683C (zh) 2003-05-28
JP2001523676A (ja) 2001-11-27
KR20010031903A (ko) 2001-04-16
NZ503988A (en) 2001-09-28
HRP20000288A2 (en) 2000-08-31
WO1999025707A1 (en) 1999-05-27
BR9813996A (pt) 2000-09-26
EP0920862A1 (en) 1999-06-09
NO20002371D0 (no) 2000-05-05
AU748395B2 (en) 2002-06-06
HUP0004731A3 (en) 2003-01-28
PL340431A1 (en) 2001-02-12
TR200001288T2 (tr) 2000-09-21
CN1278811A (zh) 2001-01-03
EA003471B1 (ru) 2003-06-26
NO20002371L (no) 2000-07-05
US6096781A (en) 2000-08-01
AU1386199A (en) 1999-06-07
CA2309859A1 (en) 1999-05-27
ID26865A (id) 2001-02-15
ZA9810214B (en) 2000-05-09
EA200000519A1 (ru) 2000-10-30
TW467909B (en) 2001-12-11
HUP0004731A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
EP1112279A4 (en) METHOD FOR THE PRODUCTION OF CONJUGATED OLIGOMERS
GB9425783D0 (en) Packaging of patches
IL135813A (en) Method for the preparation of citalopram
HUP9900790A3 (en) Imidazoquinazoline derivatives
IL135511A0 (en) 2-arylbenzo[b] thiophenes useful for the treatment of estrogen deprivation syndrome
HUP0003737A3 (en) New process for the preparation of omeprazole
HUP0004413A3 (en) Use of 2-aryl-3-aroyl-benzo[b]thiophenes for producing medicaments useful treatment of estrogen deprivation syndrome
EP0990632A4 (en) ADAMANTANEMETHANOL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
ZA981885B (en) Method for the preparation of alpha-bromo-lactam derivatives
ZA987741B (en) Process for the preparation of oxazaphosphorine-2-amines
IL135553A0 (en) Process for the preparation of azacycloalkyalkanoyl pseudotetrapeptides
EP0943607A4 (en) PROCESS FOR THE PREPARATION OF PROSTAGLANDINS
HUP0003321A3 (en) Process for the preparation of 2-alkylthiobenzonitrile derivatives
IL132237A0 (en) Process for the preparation of 3-isochromanome
ZA981924B (en) Process for the preparation of n-carboxylalkyl-3-fluoro-4- dialkylaminoanilines
SI1068184T1 (en) N-aryloxyethylamine derivatives for the treatment of depression
ZA959752B (en) Thiophene derivatives
TW389228U (en) Improved leg structure for conveyor waveborad
SI1068199T1 (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression
TW360354U (en) Timprovement for positioned structure of pivot
IL135641A0 (en) Method for the preparation of citalopram
ZA985981B (en) Method for the preparation of citalopram
IL152953A0 (en) Method for the preparation of citalopram
IL153125A0 (en) Method for the preparation of citalopram
SI1042310T1 (en) Method for the preparation of citalopram